ARAVIVE, INC (ARAV) vs Onconetix, Inc. (ONCO)
- ARAVIVE, INC ARAV
- Onconetix, Inc. ONCO 0.48 −12.73%
ARAVIVE, INC and Onconetix, Inc. are both Biotechnology companies. ARAVIVE, INC and Onconetix, Inc. are of similar size ($3.0M and $2.9M). ARAVIVE, INC has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. ARAVIVE, INC grew revenue faster over the last twelve months: −19.1% against −51.3%. ARAVIVE, INC has the higher net margin (−569.7% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 17 metrics below, Onconetix, Inc. leads on 9 and ARAVIVE, INC on 8.
Valuation
Profitability
| Metric | ARAV | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 80.38% | 65.16% |
| Operating margin | (847.42%) | (2,524.73%) | 0.00% |
| Net margin | (569.65%) | (1,578.60%) | 0.00% |
| Free cash flow margin | (849.92%) | (1,595.90%) | 0.00% |
| Return on equity | (475.98%) | (105.23%) | (56.36%) |
| Return on assets | (144.19%) | (57.37%) | (48.04%) |
| Return on invested capital | 0.00% | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack